151 related articles for article (PubMed ID: 17504267)
1. A comparative study of proteasomal inhibition and apoptosis induced in N27 mesencephalic cells by dopamine and MG132.
Zafar KS; Inayat-Hussain SH; Ross D
J Neurochem; 2007 Aug; 102(3):913-21. PubMed ID: 17504267
[TBL] [Abstract][Full Text] [Related]
2. Proteasome inhibitor MG-132 induces dopaminergic degeneration in cell culture and animal models.
Sun F; Anantharam V; Zhang D; Latchoumycandane C; Kanthasamy A; Kanthasamy AG
Neurotoxicology; 2006 Sep; 27(5):807-15. PubMed ID: 16870259
[TBL] [Abstract][Full Text] [Related]
3. Apoptotic signaling in dopamine-induced cell death: the role of oxidative stress, p38 mitogen-activated protein kinase, cytochrome c and caspases.
Junn E; Mouradian MM
J Neurochem; 2001 Jul; 78(2):374-83. PubMed ID: 11461973
[TBL] [Abstract][Full Text] [Related]
4. Blockade of PKCdelta proteolytic activation by loss of function mutants rescues mesencephalic dopaminergic neurons from methylcyclopentadienyl manganese tricarbonyl (MMT)-induced apoptotic cell death.
Anantharam V; Kitazawa M; Latchoumycandane C; Kanthasamy A; Kanthasamy AG
Ann N Y Acad Sci; 2004 Dec; 1035():271-89. PubMed ID: 15681813
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological inhibition of neuronal NADPH oxidase protects against 1-methyl-4-phenylpyridinium (MPP+)-induced oxidative stress and apoptosis in mesencephalic dopaminergic neuronal cells.
Anantharam V; Kaul S; Song C; Kanthasamy A; Kanthasamy AG
Neurotoxicology; 2007 Sep; 28(5):988-97. PubMed ID: 17904225
[TBL] [Abstract][Full Text] [Related]
6. Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis.
Jiang H; Ren Y; Zhao J; Feng J
Hum Mol Genet; 2004 Aug; 13(16):1745-54. PubMed ID: 15198987
[TBL] [Abstract][Full Text] [Related]
7. Differential effect of nerve growth factor on dopaminergic neurotoxin-induced apoptosis.
Hirata Y; Meguro T; Kiuchi K
J Neurochem; 2006 Oct; 99(2):416-25. PubMed ID: 17029596
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress, induced by 6-hydroxydopamine, reduces proteasome activities in PC12 cells: implications for the pathogenesis of Parkinson's disease.
Elkon H; Melamed E; Offen D
J Mol Neurosci; 2004; 24(3):387-400. PubMed ID: 15655261
[TBL] [Abstract][Full Text] [Related]
9. Death of dopaminergic neurons in vitro and in nigral grafts: reevaluating the role of caspase activation.
Hurelbrink CB; Armstrong RJ; Luheshi LM; Dunnett SB; Rosser AE; Barker RA
Exp Neurol; 2001 Sep; 171(1):46-58. PubMed ID: 11520120
[TBL] [Abstract][Full Text] [Related]
10. Microarray analysis of oxidative stress regulated genes in mesencephalic dopaminergic neuronal cells: relevance to oxidative damage in Parkinson's disease.
Anantharam V; Lehrmann E; Kanthasamy A; Yang Y; Banerjee P; Becker KG; Freed WJ; Kanthasamy AG
Neurochem Int; 2007 May; 50(6):834-47. PubMed ID: 17397968
[TBL] [Abstract][Full Text] [Related]
11. Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson's disease?
Hartmann A; Michel PP; Troadec JD; Mouatt-Prigent A; Faucheux BA; Ruberg M; Agid Y; Hirsch EC
J Neurochem; 2001 Mar; 76(6):1785-93. PubMed ID: 11259496
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of proteasome activity sensitizes dopamine neurons to protein alterations and oxidative stress.
Mytilineou C; McNaught KS; Shashidharan P; Yabut J; Baptiste RJ; Parnandi A; Olanow CW
J Neural Transm (Vienna); 2004 Oct; 111(10-11):1237-51. PubMed ID: 15480836
[TBL] [Abstract][Full Text] [Related]
13. Glial cell-derived neurotrophic factor protects against proteasome inhibition-induced dopamine neuron degeneration by suppression of endoplasmic reticulum stress and caspase-3 activation.
Li X; Peng C; Li L; Ming M; Yang D; Le W
J Gerontol A Biol Sci Med Sci; 2007 Sep; 62(9):943-50. PubMed ID: 17895431
[TBL] [Abstract][Full Text] [Related]
14. Cyanide enhancement of dopamine-induced apoptosis in mesencephalic cells involves mitochondrial dysfunction and oxidative stress.
Jones DC; Prabhakaran K; Li L; Gunasekar PG; Shou Y; Borowitz JL; Isom GE
Neurotoxicology; 2003 Jun; 24(3):333-42. PubMed ID: 12782099
[TBL] [Abstract][Full Text] [Related]
15. Proteasome inhibition by MG-132 induces apoptotic cell death and mitochondrial dysfunction in cultured rat brain oligodendrocytes but not in astrocytes.
Goldbaum O; Vollmer G; Richter-Landsberg C
Glia; 2006 Jun; 53(8):891-901. PubMed ID: 16609961
[TBL] [Abstract][Full Text] [Related]
16. 6-Hydroxydopamine increases ubiquitin-conjugates and protein degradation: implications for the pathogenesis of Parkinson's disease.
Elkon H; Melamed E; Offen D
Cell Mol Neurobiol; 2001 Dec; 21(6):771-81. PubMed ID: 12043847
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of vesicular monoamine transporter enhances vulnerability of dopaminergic cells: relevance to Parkinson's disease.
Choi HJ; Lee SY; Cho Y; Hwang O
Neurochem Int; 2005 Mar; 46(4):329-35. PubMed ID: 15707697
[TBL] [Abstract][Full Text] [Related]
18. Application of proteasomal inhibitors to mouse sympathetic neurons activates the intrinsic apoptotic pathway.
Lang-Rollin I; Vekrellis K; Wang Q; Rideout HJ; Stefanis L
J Neurochem; 2004 Sep; 90(6):1511-20. PubMed ID: 15341534
[TBL] [Abstract][Full Text] [Related]
19. Induction and attenuation of neuronal apoptosis by proteasome inhibitors in murine cortical cell cultures.
Suh J; Lee YA; Gwag BJ
J Neurochem; 2005 Nov; 95(3):684-94. PubMed ID: 16144541
[TBL] [Abstract][Full Text] [Related]
20. Partial dopamine loss enhances activated caspase-3 activity: differential outcomes in striatal projection systems.
Ariano MA; Grissell AE; Littlejohn FC; Buchanan TM; Elsworth JD; Collier TJ; Steece-Collier K
J Neurosci Res; 2005 Nov; 82(3):387-96. PubMed ID: 16180225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
